Looming threats to pharmaceuticals and the drug supply chain have brought fresh attention to onshoring. Experts say ...

President Trump has threatened to slap a 200% tariff on foreign-made pharmaceuticals. That would roil the $200 billion-plus ...

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...

The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exits ...